Earlier this month, President Biden signed into law S. 3373, “The Sergeant First Class Heath Robinson Honoring Our Promises to Address Comprehensive Toxics (PACT) Act of 2022.”
Prostate Cancer Foundation President and CEO Dr. Charles J. Ryan had the privilege of representing PCF at the White House signing ceremony. The PACT Act marked the most significant expansion of Veterans Affairs (VA) healthcare in 30 years.
The White House reports that the PACT Act will:
- Expand access to VA health care and benefits for toxic-exposed veterans and their survivors
- Improve care and increase research related to toxic exposures
- Provide VA with important resources to serve veterans, their families, caregivers, and survivors
Notably, the legislation also supports President Biden’s reignited Cancer Moonshot to help end cancer. It includes provisions to study incident rates of cancer among Veterans.
On this occasion, PCF celebrated its commitment to Veterans and military families fighting prostate cancer. Through a multi-year commitment to advancing best-in-class prostate cancer research, treatment, and care serving Veterans, PCF has been at the forefront of serving our nation’s heroes, including those exposed to toxic exposures, who are fighting prostate cancer.
Prostate cancer is currently the number one cancer diagnosed among Veterans, and PCF has provided $50 million in funding to advance the largest public-private disease-specific cancer partnership serving Veterans since 2016.
